Christine Caulfield

Biopharmaceutical company Amgen has lodged proceedings against generic maker Sandoz, calling for documents related to regulatory approval of a generic version of its top-selling bone disease treatments.

It lost its bid in the NSW Supreme Court to withhold a payment claim from the builder of a 30-storey project in Sydney pending an appeal, now developer VSD Investments has asked an appeals court to halt payment.

Kent Projects, the engineering firm behind the world-first Kwinana energy transformation hub in WA, is not giving up its fight against fraud claims in a case by the CFMEU.

Property giant Mirvac Group is in talks with a potential capital partner for its Harbourside development in Sydney, as it progresses construction on the major waterfront project.

A criminal defence lawyer sexually harassed a female paralegal who worked at his Fremantle firm, according to a suit that details a series of alleged incidents, including a request that she wear his wife's court robes.

Logistics company Qube wants the High Court to clarify the scope of an adjudicator's role in determining a contractor's payment claims under the SOP Act.

Infrastructure and real asset investment firm Stonepeak has entered a deal to acquire a 75 per cent interest in Queensland-based commercial fuel and logistics provider IOR Group.

A former cryptocurrency boss who faces a criminal investigation by ASIC is on the hook for a $10.3 million Bitcoin payout to a former employee, a court has found.

Developer Australia YMCI has reached an agreement with Parramatta on its application for remediation works at its $5B Ovation Quarter residential complex at Sydney Olympic Park.

Dairy company Fonterra can't get a court declaration that its Australian exit plans will not trigger change of control clauses in lucrative licence agreements with Bega, potentially affecting the likely sale price.